Page 1046 - medicina-integrativa_compress
P. 1046

CAPÍTULO 103  PRESCRIPCIÓN DE ANTIOXIDANTES    1075

             187. Gurkan AS: Syntheses of novel indole lipoic acid derivatives and  tumorigenic parotid acinar cells in culture. Nutr Cancer 26:11-19,
                their antioxidant effects on lipid peroxidation. Arch Pharm  1996.
                (Weinheim) 338:67-73, 2005.                     197. Lamson DW, Brignall MS: Antioxidants in cancer therapy: Their
             188. Bandyopadhyay D, Biswas K, Bhattacharyya M, et al: Gastric toxicity  actions and interactions with oncologic therapies. Alt Med Rev
                and mucosal ulceration induced by oxygen-derived reactive species:  4:304-329, 1999.
                Protection by melatonin. Curr Mol Med 1:501-513, 2001.  198. Lamm DL, Riggs DR, Shriver JS, et al: Megadose vitamins in bladder
             189. Randhir R: Phenolics, their antioxidant and antimicrobial activity in  cancer: A double-blind clinical trial. J Urol 151:21-26, 1994.
                dark germinated fenugreek sprouts in response to peptide and  199. Virtamo J, Pietenen P, Huttunen JK, et al: Incidence of cancer and
                phytochemical elicitors. Asia Pac J Clin Nutr 13:295-307, 2004.  mortality following alpha-tocopherol and beta-carotene
             190. Yen WJ, Wang BS, Chang LW, et al: Antioxidant properties of  supplementation: A postintervention follow-up. JAMA 290:476-485,
                roasted coffee residues. J Agric Food Chem 53:2658-2663, 2005.  2003.
             191. Ariga T: The antioxidative function, preventive action on disease  200. Salonen RM, Nyyssonen K, Kaikkonen J, et al: Six-year effect of
                and utilization of proanthocyanidins. Biofactors 21:197-201, 2004.  combined vitamin C and E supplementation on atherosclerotic
             192. Wagdi P, Fluri M, Aeschbacher B, et al: Cardioprotection in patients  progression: The Antioxidant, Supplementation in Atherosclerosis
                undergoing chemo- and/or radiotherapy for neoplastic disease:   Prevention (ASAP) Study. Circulation 107:947-953, 2003.
                A pilot study. Jpn Heart J 37:353-359, 1996.    201. Davi G, Falco A, Patrono C: Determinants of F2-isoprostane
             193. Sieja K: Selenium (Se) deficiency in women with ovarian cancer  biosynthesis and inhibition in man. Chem Phys Lipids 128:149-163,
                undergoing chemotherapy and the influence of supplementation  2004.
                with this micro-element on biochemical parameters. Pharmazie  202. Vivekananthan DP, Penn MS, Sapp SK, et al: Use of antioxidant
                53:473-476, 1998.                                   vitamins for the prevention of cardiovascular disease: Meta-analysis
             194. Lee IM: Antioxidant vitamins in the prevention of cancer. Proc  of randomised trials. Lancet 361:2017-2023, 2003.
                Assoc Am Physicians 111:10-15, 1999.            203. Liao JK: Statin therapy for cardiac hypertrophy and heart failure.
             195. Prasad KN, Kumar A, Kochupillai V, et al: High doses of multiple  J Invest Med 52:248-53, 2004.
                antioxidant vitamins: Essential ingredients in improving the efficacy  204. González MJ, Miranda-Massari JR, Mora EM, et al:
                of standard cancer therapy. J Am Coll Nutr 18:13-25, 1999.  Orthomolecular oncology: A mechanistic view of intravenous
             196. Prasad KN, Kumar R: Effect of individual and multiple antioxidant  ascorbate’s chemotherapeutic activity. P R Health Sci J 21:39-41,
                vitamins on growth and morphology of human nontumorigenic and  2002.



























           © Elsevier. Es una publicación MASSON. Fotocopiar sin autorización es un delito.
   1041   1042   1043   1044   1045   1046   1047   1048   1049   1050   1051